TERN
Terns Pharmaceuticals Inc
NASDAQ: TERN · HEALTHCARE · BIOTECHNOLOGY
$52.92
-0.04% today
Updated 2026-04-29
Market cap
$6.11B
P/E ratio
—
P/S ratio
302.64x
EPS (TTM)
$-1.03
Dividend yield
—
52W range
$3 – $53
Volume
6.6M
Terns Pharmaceuticals Inc (TERN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.07M | $-66.22M | $-29.81M | $-41.83M | $-49.11M | $-67.39M | $-70.02M | $-82.18M |
| Capital expenditures | $244000.00 | $900000.00 | $584000.00 | $340000.00 | $275000.00 | $52000.00 | $42000.00 | $0.00 |
| Depreciation | $65000.00 | $195000.00 | $394000.00 | $512000.00 | $1.03M | $881000.00 | $896000.00 | — |
| Stock-based comp | $234000.00 | $668000.00 | $1.69M | $8.15M | $10.77M | $25.54M | $15.63M | $13.40M |
| Free cash flow | $-18.32M | $-67.12M | $-30.39M | $-42.17M | $-49.38M | $-67.44M | $-70.06M | $-82.18M |
| Investing cash flow | $-4.78M | $-3.86M | $6.69M | $-119.70M | $-22.27M | $-37.99M | $-12.41M | — |
| Financing cash flow | $99.76M | $62000.00 | $85.52M | $134.39M | $167.09M | $41.95M | $164.00M | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $95.71M | — | — | — |